Investors
Regen Lab is a portfolio medical technology
company focused on the repair, regeneration
and replacement of soft and hard tissue.
Regen Lab is a Swiss medical device company dedicated to advancing autologous regenerative medicine through standardised, reliable and easy-to-use technologies.
Since 2003, Regen Lab has developed and manufactured medical devices designed to support healthcare professionals in the preparation of autologous platelet-rich plasma and related biological preparations. By combining scientific expertise, quality manufacturing and a strong commitment to clinical education, Regen Lab contributes to the responsible development of regenerative medicine across a broad range of medical fields.
Our approach is built on standardisation, reproducibility and compliance, helping healthcare professionals integrate autologous solutions into their practice within a rigorous medical and regulatory framework. Through an international network of partners, clinicians and scientific collaborators, Regen Lab continues to support evidence-based innovation in regenerative medicine worldwide.
Our strategy
Our Marketplace
Regen Lab’s strategy is to strengthen its position as a reference company in autologous regenerative medicine by combining medical device innovation, scientific evidence, clinical education and international development.
Our focus is to provide healthcare professionals with standardised and reliable technologies for the preparation of autologous biological solutions, while supporting responsible clinical practice through training, research and regulatory compliance.
By expanding access to its technologies, developing new scientific collaborations and continuously improving its product platforms, Regen Lab aims to contribute to the advancement of evidence-based regenerative medicine worldwide.
Regen Lab’s strategy is to strengthen its position as a reference company in autologous regenerative medicine by combining medical device innovation, scientific evidence, clinical education and international development.
Our focus is to provide healthcare professionals with standardised and reliable technologies for the preparation of autologous biological solutions, while supporting responsible clinical practice through training, research and regulatory compliance.
By expanding access to its technologies, developing new scientific collaborations and continuously improving its product platforms, Regen Lab aims to contribute to the advancement of evidence-based regenerative medicine worldwide.
Quarterly Results
View all previous quarterly results
Quarterly Results
Financial Planning
Cras ultricies ligula sed magna dictum porta. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere.
Quarterly Results
Financial Planning
Cras ultricies ligula sed magna dictum porta. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere.
Quarterly Results
Financial Planning
Cras ultricies ligula sed magna dictum porta. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere.
Quarterly Results
Regen Lab First Quarter 2026
Quarterly Results
Regen Lab First Quarter 2026
Quarterly Results
Regen Lab First Quarter 2026
Q1 2026 Trading Report
We released our Q1 2026 Trading Report on Wednesday 6 May.
You can ask to watch a replay of the webcast for analysts below.
Financial calendar
10 May
Q1 Trading Report
10 May
Q1 Trading Report
10 May
Q1 Trading Report
10 May
Q1 Trading Report
Regen Lab Expert Surgeon Insights Event
We will be hosting an expert surgeon insights event for investors and financial analysts.
Date: 9 June 2026
Time: 8.30am – 12.45pm
Reports + Presentations
View the previous reports and presentations
Quarterly Results
Regen Lab First Quarter 2026
Quarterly Results
Regen Lab First Quarter 2026
Quarterly Results
Regen Lab First Quarter 2026
Quarterly Results
Regen Lab First Quarter 2026
Quarterly Results
Regen Lab First Quarter 2026
Quarterly Results
Regen Lab First Quarter 2026
News and Announcements
Votre titre va ici
Explore
Votre titre va ici
Explore
Votre titre va ici
Explore
Votre titre va ici
Explore
Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies.
CONTACT US
Discover innovative regenerative medicine solutions with Regen Lab – contact us today to elevate your treatments and enhance patient care!